Jack of All Trades: SKORE 02.10.2026
Coke's record 31.2% margin couldn't offset volume stagnation (flat FY25) and 4-5% organic growth deceleration, while Gilead's 45% operating margin expansion (from 30%) and Yeztugo launch success prove HIV franchise durability to 2036—defensive quality diverges based on moat sustainability